ARCHIVES

In Vote Against Tarceva As Maintenance, ODAC Seeks Stronger Survival Benefit

This article is from The Cancer Letter archive.

Vol. 35 No. 46 | December 18, 2009

Download PDF Visit The Full Archive

Related Articles

NCI to Fund Research Collaboration At HMOs, Health Care Provider Networks

July 11, 1997

GAO Investigation Of Cancer Control Focuses On Five Contracts, Finds Alleged Deficiencies

July 18, 1980

Murray Copeland Display Dedicated

March 18, 1983

AVEO’s Tivozanib Sunk by Fundamental Flaw: Higher Overall Survival in the Control Arm

May 8, 2013

Old MSK Grant Reprogrammed, NIC Makes Final 1985 Construction Awards

July 5, 1985

NCI’s Share Of Gramm-Rudman Cuts For FY 1986 Is $54 Million; Staff Ponders How To Absorb It

January 24, 1986